Impact of airflow limitation in chronic heart failure. - Wikidata - wikimedia - TriplyDB

Impact of airflow limitation in chronic heart failure.

Impact of airflow limitation in chronic heart failure.

http://www.wikidata.org/entity/Q33603101

about

An old debate still in the β-phase?

P2860

Q47658450-597065FA-D61E-41BA-8DE7-CFD8610BAF35

P2860

Impact of airflow limitation in chronic heart failure.

http://www.wikidata.org/entity/Q33603101

description

2017 nî lūn-bûn

@nan

2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Impact of airflow limitation in chronic heart failure.

@ast

Impact of airflow limitation in chronic heart failure.

@en

type

label

Impact of airflow limitation in chronic heart failure.

@ast

Impact of airflow limitation in chronic heart failure.

@en

prefLabel

Impact of airflow limitation in chronic heart failure.

@ast

Impact of airflow limitation in chronic heart failure.

@en

P1433

Q33603101-E5921B1F-52B9-4577-A6FD-1ACC4F2AA04D

P1476

Q33603101-2B274280-966F-4860-8F05-EEC373143F7F

P2093

Q33603101-43D938A6-F4F6-4D2C-8B9B-C92370A88772

Q33603101-590DDBA3-22EF-482B-B4E9-9E8BFE814129

Q33603101-689B048A-8436-4B20-92DD-8E0B7DE881BC

Q33603101-8EB1CD5B-B7DB-428C-849B-9D498043635A

Q33603101-9112B38C-C1FD-4332-87EE-511F3B005930

Q33603101-D7F04E07-85AA-41B7-B586-FF4F173E807A

Q33603101-FE0F42D1-9272-4440-9864-9784670C02A7

P2860

Q33603101-02E2FFEC-0571-4D82-946E-4BB43ADD6A8C

Q33603101-095A8B77-0BE3-4849-98B0-5938F6F87F84

Q33603101-1394874F-C1B4-441F-9B25-25FAEAD7FAE0

Q33603101-19F58193-9FE1-4146-A885-E62FA5317754

Q33603101-20831A9C-CFE1-4A7F-8098-EEFE19C2280A

Q33603101-21B91B3B-7522-48A2-AA70-9A51101F980F

Q33603101-2AA9ADEE-681A-401E-B2A3-4D64F9B8EDA6

Q33603101-2D3243D9-80AB-48AE-ADE5-80ED25F03AC8

Q33603101-312AECE2-3BA2-4AC5-9132-3C5718464353

Q33603101-333BD1F3-D0D3-4C2F-9208-C279A0FF822E

P2888

Q33603101-FB7E20F9-F353-4452-9502-C04EC1CEC76B

P304

Q33603101-9FC83290-528E-49F9-AAEE-F52CE7C5D62D

P31

Q33603101-05ECA0AD-6658-440D-B9A1-28A32E251204

P356

Q33603101-204BAE98-7834-47FC-AD4C-3D9B57C2E8D5

P433

Q33603101-B8CFE7CB-2C0B-432F-AC5B-C8C1624C1027

P478

Q33603101-75F47AE7-DD8C-4491-BFC3-2B35D1586C45

P577

Q33603101-FB0E15C1-2D7C-4FC0-8A56-CED50385CDBB

P6179

Q33603101-729B08BF-5155-499B-B9C4-FC6024A8F8D0

P698

Q33603101-F71897C3-2FD5-4FFE-9442-0EC38718B0AC

P932

Q33603101-A4184FA9-D48A-45D1-A846-E9CB31B9915F

P356

S12471-017-0965-4

P1433

Netherlands Heart Journal

P1476

Impact of airflow limitation in chronic heart failure.

@en

P2093

C Knackstedt

http://www.w3.org/2001/XMLSchema#string

F M E Franssen

http://www.w3.org/2001/XMLSchema#string

H P Brunner-La Rocca

http://www.w3.org/2001/XMLSchema#string

J Boyne

http://www.w3.org/2001/XMLSchema#string

N Uszko-Lencer

http://www.w3.org/2001/XMLSchema#string

S Bektas

http://www.w3.org/2001/XMLSchema#string

V van Empel

http://www.w3.org/2001/XMLSchema#string

P2860

Outcome of heart failure with preserved ejection fraction in a population-based study

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Standardisation of spirometry

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary

International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

Prevalence of symptomatic heart failure with reduced and with normal ejection fraction in an elderly general population-the CARLA study.

Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology

Prevalence of airflow limitation in outpatients with cardiovascular diseases in Japan.

ATS statement: guidelines for the six-minute walk test.

P2888

s12471-017-0965-4

P304

335-342

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12471-017-0965-4

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084035267

http://www.w3.org/2001/XMLSchema#string

P698

28244013

http://www.w3.org/2001/XMLSchema#string

P932

5405029

http://www.w3.org/2001/XMLSchema#string